Orion Oyj B (HE:ORNBV) — Market Cap & Net Worth
Market Cap & Net Worth: Orion Oyj B (ORNBV)
Orion Oyj B (HE:ORNBV) has a market capitalization of $8.48 Billion (€7.25 Billion) as of May 5, 2026. Listed on the HE stock exchange, this Finland-based company holds position #2521 globally and #10 in its home market, demonstrating a -6.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Orion Oyj B's stock price €68.70 by its total outstanding shares 108851517 (108.85 Million). Analyse cash flow conversion of Orion Oyj B to see how efficiently the company converts income to cash.
Orion Oyj B Market Cap History: 2015 to 2026
Orion Oyj B's market capitalization history from 2015 to 2026. Data shows growth from $2.84 Billion to $8.74 Billion (10.85% CAGR).
Orion Oyj B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Orion Oyj B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.53x
Orion Oyj B's market cap is 3.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
16.50x
Orion Oyj B's market cap is 16.50 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.84 Billion | $1.02 Billion | $208.20 Million | 2.80x | 13.66x |
| 2016 | $3.93 Billion | $1.07 Billion | $249.00 Million | 3.66x | 15.79x |
| 2017 | $2.97 Billion | $1.08 Billion | $226.00 Million | 2.74x | 13.13x |
| 2018 | $3.05 Billion | $977.40 Million | $330.30 Million | 3.12x | 9.24x |
| 2019 | $4.35 Billion | $1.05 Billion | $200.40 Million | 4.14x | 21.69x |
| 2020 | $4.08 Billion | $1.08 Billion | $219.90 Million | 3.78x | 18.55x |
| 2021 | $4.15 Billion | $1.04 Billion | $193.80 Million | 3.98x | 21.40x |
| 2022 | $6.03 Billion | $1.34 Billion | $349.50 Million | 4.50x | 17.26x |
| 2023 | $4.80 Billion | $1.19 Billion | $216.80 Million | 4.04x | 22.14x |
| 2024 | $5.44 Billion | $1.54 Billion | $329.90 Million | 3.53x | 16.50x |
Competitor Companies of ORNBV by Market Capitalization
Companies near Orion Oyj B in the global market cap rankings as of May 5, 2026.
Key companies related to Orion Oyj B by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #16 globally with a market cap of $862.20 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #23 globally with a market cap of $547.37 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #37 globally with a market cap of $365.30 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16 | Eli Lilly and Company | NYSE:LLY | $862.20 Billion | $963.33 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #23 | Johnson & Johnson | NYSE:JNJ | $547.37 Billion | $227.19 |
| #37 | AbbVie Inc | NYSE:ABBV | $365.30 Billion | $206.60 |
Orion Oyj B Historical Marketcap From 2015 to 2026
Between 2015 and today, Orion Oyj B's market cap moved from $2.84 Billion to $ 8.74 Billion, with a yearly change of 10.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €8.74 Billion | +7.93% |
| 2025 | €8.10 Billion | +48.78% |
| 2024 | €5.44 Billion | +13.41% |
| 2023 | €4.80 Billion | -20.40% |
| 2022 | €6.03 Billion | +45.41% |
| 2021 | €4.15 Billion | +1.67% |
| 2020 | €4.08 Billion | -6.16% |
| 2019 | €4.35 Billion | +42.49% |
| 2018 | €3.05 Billion | +2.81% |
| 2017 | €2.97 Billion | -24.51% |
| 2016 | €3.93 Billion | +38.18% |
| 2015 | €2.84 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Orion Oyj B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.48 Billion USD |
| MoneyControl | $8.48 Billion USD |
| MarketWatch | $8.48 Billion USD |
| marketcap.company | $8.48 Billion USD |
| Reuters | $8.48 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Orion Oyj B
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflam… Read more